Analysts use this formula to calculate it for Batu Kawan Berhad: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.073 = RM1.8b ÷ ...

Frank Chan joins Haemonetics as Executive Vice President, Chief Operating Officer; Roy Galvin named Executive Vice President, Chief Commercial Officer As Chief Operating Officer, Chan will direct ...

BOSTON, March 3, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...

Haemonetics describes itself as an innovative medical technology solution provider, aiming to improve quality, effectiveness and efficiency of care. The company generates about $1.3 billion in ...

Haemonetics Stock Performance HAE stock opened at $68.70 on Monday. The company has a quick ratio of 2.55, a current ratio of 3.97 and a debt-to-equity ratio of 1.35. The company has a market ...

BOSTON, Feb. 24, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James ...

Haemonetics has a 1-year low of $58.80 and a 1-year high of $97.97. The company has a market capitalization of $3.45 billion, a PE ratio of 27.05, a PEG ratio of 1.11 and a beta of 0.43.

BOSTON - Haemonetics Corporation (NYSE: NYSE:HAE), a global medical technology company with a market capitalization of $3.26 billion and annual revenue of $1.37 billion, has announced changes to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...